DaVita Inc. (NYSE:DVA) Shares Acquired by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. boosted its holdings in DaVita Inc. (NYSE:DVA) by 0.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 12,854 shares of the company’s stock after buying an additional 118 shares during the quarter. PNC Financial Services Group Inc.’s holdings in DaVita were worth $1,922,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. MML Investors Services LLC grew its position in DaVita by 1.3% in the third quarter. MML Investors Services LLC now owns 5,300 shares of the company’s stock worth $869,000 after buying an additional 68 shares during the last quarter. Exchange Traded Concepts LLC grew its position in DaVita by 8.3% in the fourth quarter. Exchange Traded Concepts LLC now owns 891 shares of the company’s stock worth $133,000 after buying an additional 68 shares during the last quarter. Impact Partnership Wealth LLC grew its position in DaVita by 3.7% in the fourth quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company’s stock worth $290,000 after buying an additional 70 shares during the last quarter. Contravisory Investment Management Inc. grew its position in DaVita by 1.2% in the fourth quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company’s stock worth $910,000 after buying an additional 73 shares during the last quarter. Finally, Nilsine Partners LLC grew its position in DaVita by 0.8% in the fourth quarter. Nilsine Partners LLC now owns 11,160 shares of the company’s stock worth $1,669,000 after buying an additional 92 shares during the last quarter. Institutional investors and hedge funds own 90.12% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the stock. Cowen reaffirmed a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price objective on shares of DaVita in a research note on Friday, February 21st. Finally, Barclays raised their price objective on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $166.33.

DaVita Trading Up 1.7 %

Shares of NYSE:DVA opened at $143.56 on Friday. The firm has a fifty day moving average of $158.92 and a two-hundred day moving average of $157.60. The firm has a market capitalization of $11.48 billion, a P/E ratio of 13.37, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99. DaVita Inc. has a 12-month low of $125.64 and a 12-month high of $179.60. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA) last issued its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, equities analysts expect that DaVita Inc. will post 10.76 EPS for the current fiscal year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.